These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 33955229)
21. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803 [TBL] [Abstract][Full Text] [Related]
22. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial). Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214 [TBL] [Abstract][Full Text] [Related]
23. The relationship of all-cause mortality to average on-treatment systolic blood pressure is significantly related to baseline systolic blood pressure: implications for interpretation of the Systolic Blood Pressure Intervention Trial study. Okin PM; Kjeldsen SE; Devereux RB J Hypertens; 2018 Apr; 36(4):916-923. PubMed ID: 29176391 [TBL] [Abstract][Full Text] [Related]
24. Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial. Plante TB; Juraschek SP; Zakai NA; Tracy RP; Cushman M Am J Cardiol; 2019 Dec; 124(11):1701-1706. PubMed ID: 31575423 [TBL] [Abstract][Full Text] [Related]
25. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial. Attar A; Sayadi M; Jannati M Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671 [TBL] [Abstract][Full Text] [Related]
26. Impact of the SPRINT Trial on Hypertension Management. Ghazi L; Oparil S Annu Rev Med; 2018 Jan; 69():81-95. PubMed ID: 29414255 [TBL] [Abstract][Full Text] [Related]
34. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268 [TBL] [Abstract][Full Text] [Related]
35. Heart failure and the discrepancy between trials of intensive blood pressure management: an analysis of individual patient data. Aggarwal R; Mirzan H; Chiu N; Steinkamp J Clin Res Cardiol; 2018 Jul; 107(7):565-569. PubMed ID: 29480390 [TBL] [Abstract][Full Text] [Related]